Cargando…
Umbilical Cord Blood and Cord Tissue-Derived Cell Therapies for Neonatal Morbidities: Current Status and Future Challenges
Cell therapies are an emerging focus for neonatal research, with benefits documented for neonatal respiratory, neurological, and cardiac conditions in pre-clinical studies. Umbilical cord blood (UCB) and umbilical cord (UC) tissue-derived cell therapy is particularly appealing for preventative or re...
Autores principales: | Zhou, Lindsay, McDonald, Courtney, Yawno, Tamara, Jenkin, Graham, Miller, Suzanne, Malhotra, Atul |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8929446/ https://www.ncbi.nlm.nih.gov/pubmed/35259278 http://dx.doi.org/10.1093/stcltm/szab024 |
Ejemplares similares
-
Factors Influencing the Efficacy of Umbilical Cord Blood-Derived Cell Therapy for Perinatal Brain Injury
por: Purcell, Elisha, et al.
Publicado: (2023) -
Umbilical Cord Blood Transplantation: Connecting Its Origin to Its Future
por: Sanchez-Petitto, Gabriela, et al.
Publicado: (2023) -
Allogeneic Cell Therapy Applications in Neonates: A Systematic Review
por: Razak, Abdul, et al.
Publicado: (2023) -
Effect of expansion of human umbilical cord blood CD34 + cells on neurotrophic and angiogenic factor expression and function
por: Watt, Ashalyn P., et al.
Publicado: (2022) -
Umbilical cord blood: The promise and the uncertainty
por: Kindwall‐Keller, Tamila L., et al.
Publicado: (2020)